Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Targeted Anticancer Therapies Congress 2025

The corporate and investor mindset: What types of anti-cancer drugs and clinical research proposals will be prioritised in the near term?

Panel discussion

Date

05 Mar 2025

Session

The corporate and investor mindset: What types of anti-cancer drugs and clinical research proposals will be prioritised in the near term?

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction

Presenter: Giovanni Abbadessa

Session: The corporate and investor mindset: What types of anti-cancer drugs and clinical research proposals will be prioritised in the near term?

Resources:

Slides

Webcast

The small company perspective

Presenter: Laura Soucek

Session: The corporate and investor mindset: What types of anti-cancer drugs and clinical research proposals will be prioritised in the near term?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.